Zucara Therapeutics Inc.
PrivateLast Round
Series B
May 1, 2025
Total Funding Raised
$52.76M
Company Overview
Zucara Therapeutics Inc. is a biotechnology company developing ZT-01, a first-in-class, once-daily therapeutic to prevent hypoglycemia in people with Type 1 and other insulin-dependent types of diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zucara Therapeutics Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Zucara Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2025 | ||||
| Grant | Jun 15, 2023 | ||||
| Grant | May 2, 2022 | ||||
| Grant | Nov 2, 2020 | ||||
| Series A | Mar 31, 2020 | ||||
Grant | Jul 12, 2019 |
Key People
Founding team and executive leadership
Zucara Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Glycomics Network | Grant |
| Perceptive Advisors | Series B, Series A |
| Helmsley Charitable Trust | Debt |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Mitacs | Grant |
| JDRF | Series B, Grant |
| TIAP | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors increased 88% MoM.
- Jun 2, 2025
Monthly visitors increased 32% MoM.
Zucara Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zucara Therapeutics Inc.'s valuation, stock price, and market status.